Sign up for free insights newsletter
RH

Roche Holding AG Participation

RHHVFUnited States

Need professional-grade analysis? Visit stockanalysis.com

$382.00
-3.29%
End of day
Market Cap

$317.75B

P/E Ratio

N/A

Employees

N/A

Dividend Yield

320.00%

Price Chart

Risk-Adjusted Performance

Ratio1W1M3M6M1Y5YScore
Sortino-0.581.340.760.62
Calmar-1.091.920.960.77
Sharpe-0.430.870.510.40
Omega0.941.211.131.11
Martin-4.157.803.272.92
Ulcer5.124.815.755.28

Roche Holding AG Participation (RHHVF) Price Performance

Roche Holding AG Participation (RHHVF) trades on United States in USD. The company is classified in the Healthcare sector under the Drug Manufacturers - General industry. The stock currently trades at $382.00, down 3.29% from the previous close.

Over the past year, RHHVF has traded between a low of $286.95 and a high of $487.10. The stock has gained 16.2% over this period. It is currently 21.6% below its 52-week high.

Roche Holding AG Participation has a market capitalization of $317.75B and a dividend yield of 320.00%.

About Roche Holding AG Participation

Roche Holding AG engages in the pharmaceuticals and diagnostics businesses in Europe, North America, Latin America, Asia, Africa, Australia, and New Zealand. The company offers pharma solutions in the therapeutic areas of anaemia, blood and solid tumors, dermatology, haematology, infectious diseases, inflammatory and autoimmune, neurological disorders, ophthalmology, respiratory disorders, and transplantation. It also provides in vitro tests for the diagnosis of various diseases, such as cancer, diabetes, Covid-19, hepatitis, human papillomavirus, and others; diagnostic instruments; and digital health solutions. The company was founded in 1896 and is based in Basel, Switzerland.

Company Info

Exchange
United States
Currency
USD

Financial Metrics

Revenue (TTM)
$63.36B
EBITDA
$24.04B
Profit Margin
20.33%
EPS (TTM)
20.22
Book Value
53.92

Technical Indicators

52 Week High
$490.33
52 Week Low
$277.00
50 Day MA
$444.93
200 Day MA
$368.44
Beta
0.21

Valuation

Trailing P/E
19.54
Forward P/E
14.86
Price/Sales
5.02
Price/Book
7.33
Enterprise Value
$329.92B